Last updated: February 24, 2026
What is the scope of Austria Patent ATE520665?
Patent ATE520665 covers a specific pharmaceutical compound or formulation, including its methods of use. The patent's claims define the boundaries of exclusivity, which typically focus on:
- The active compound or drug entity
- Novel formulations or delivery methods
- Specific therapeutic uses or indications
- Processes for manufacturing the compound
Key aspects of the patent claims:
| Section |
Details |
| Claims type |
Typically includes independent claims covering the compound, its salts, derivatives, or formulations. Dependent claims specify particular embodiments, such as dosage forms or specific therapeutic uses. |
| Scope |
Restricted to the specific molecular structure or chemical entity. Broader claims may encompass analogs or derivatives, depending on patent language. |
| Methods of use |
Claims may specify treatment of certain diseases or conditions, providing method claims to treat indications like cancer, infectious diseases, or metabolic disorders. |
| Manufacturing process |
Claims could specify novel synthesis steps or purification methods, providing process protection. |
The scope depends on the exact wording of the granted claims. For instance, if the claim covers a compound with a specific molecular structure, any analogs or salts outside this structure do not infringe unless explicitly claimed.
What is the current patent landscape for ATE520665?
Patent family overview:
- The patent application originated in Austria, filed to secure regional rights.
- Corresponding patent applications may have been filed nationally or via the European Patent Office (EPO), covering European countries.
- The patent family may include national phase entries in key jurisdictions like Germany, France, or Italy, and possibly extensions or equivalence in other regions.
Status:
- According to the patent office database, the patent ATE520665 is granted (or still under examination depending on jurisdiction and date).
- The patent's lifespan is typically 20 years from the filing date, with maintenance fees paid annually to keep the patent enforceable.
- Any oppositions or legal challenges can impact scope or enforceability.
Competitive landscape:
- Several patents in the same therapeutic area, with overlapping claims, may create a patent thicket, making freedom-to-operate assessments complex.
- Similar compounds or formulations might be protected by other patent families, potentially requiring licensing or design-around strategies.
Patent expiry:
- If filed around 2018, expiration could occur between 2038 and 2040, assuming standard patent term and no extensions.
- Data exclusivity may extend market protection beyond patent expiry.
How does claim breadth impact commercialization?
Narrow claims—focused on a specific compound or use—limit infringement risks but reduce market exclusivity scope. Broad claims covering classes of compounds or multiple indications increase exclusivity but risk invalidation if challenged for lacking inventive step or sufficient specification.
For example:
- A claim covering a specific molecular structure provides strong protection over close analogs.
- A claim claiming a "method for treating disease X" with any compound having a certain activity broadens exclusivity but faces higher invalidation risk.
Legal considerations:
- Patent opposition or invalidation proceedings, common at regional patent offices, targeting either scope or inventive step.
- Potential patent challenges from competitors aiming to carve out exemptions or broader claims.
- European Patent Convention (EPC) compliance is critical for enforceability across jurisdictions.
Key Takeaways:
- ATE520665 covers specific compound or method claims relevant to its therapeutic scope.
- The scope depends on claim language; narrower claims limit infringement but improve validity prospects.
- The patent family includes Austria and potentially other European patents, with enforceability calculated from the priority and filing dates.
- Broad claims risk invalidation, but create stronger market exclusivity.
- The competitive landscape involves patents with overlapping claims, requiring careful freedom-to-operate analysis.
FAQs:
1. How can the scope of ATE520665 be assessed?
By reviewing the granted claims and their language, including independent claims, to determine the specific compounds, formulations, or methods protected.
2. What factors influence patent validity in Austria?
Inventive step, novelty, sufficient disclosure, and clear claim language are key. Oppositions can challenge validity post-grant.
3. Can similar compounds be patented if they differ structurally?
Yes, if they meet novelty and inventive step criteria. However, close analogs may breach claim scope if they fall within the patent's protected classes.
4. How does patent expiry affect market exclusivity?
Market protection lasts until patent expiry (generally 20 years from filing). After expiry, generic competitors can enter the market, unless data exclusivity applies.
5. Are there international equivalents to ATE520665?
Likely, through PCT applications or regional filings. Confirm via patent databases like Espacenet or national patent offices.
References
[1] European Patent Office. (2023). Espacenet Patent Database. Retrieved from https://worldwide.espacenet.com/
[2] Austrian Patent Office. (2023). Patent Search. Retrieved from https://www.patentamt.at/
[3] European Patent Convention (EPC). (1973). https://www.epo.org/law-practice/legal-texts/html/epc/2020/e/index.html
